All sponsors

EMS

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS14
PHASE 3 / 2-314
RECRUITING6
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO83%

Delay Index: of 6 active trials registered more than a year ago, 5 have moved their primary completion (readout) date by more than 6 months since first registration (median +34.0 months). See all sponsors →

Open EMS on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
ALIV
NCT06237231
P3Not yet recruitingModerate Pain; Severe Pain2522025-03-15
SIERRA
NCT06272409
P3Not yet recruitingAllergic Rhinitis3182025-03-15
Praga formulation
NCT04666714
P3RecruitingNeuropathic Pain1362025-09-30
Minoxidil + finasteride
NCT04594018
P3RecruitingAndrogenetic Alopecia1902026-05 (+37 mo)
DÁLIA
NCT05886088
P3Not yet recruitingType 2 Diabetes Mellitus5972026-05
BERLIM 25/20 ASSOCIATION
NCT04602754
P3RecruitingDyslipidemia Associated With Type II Diabetes Mellitus2282026-05 (+30 mo)
AUSTRÁLIA
NCT06264414
P3Not yet recruitingProstatic Hyperplasia, Benign; Erectile Dysfunction2622026-06
ASTRAL
NCT05640232
P3RecruitingPrimary Dysmenorrhea2382026-06-28 (+16 mo)
MADALENA ASSOCIATION
NCT04670666
P3RecruitingType 2 Diabetes Mellitus2702026-07 (+35 mo)
PIEMONTE
NCT05028140
P3RecruitingType II Diabetes4802026-07 (+34 mo)
GENERA
NCT05824065
P3Not yet recruitingFemale Pattern Baldness5042027-01
LIBERTÀ
NCT06268054
P3Not yet recruitingPrimary Dysmenorrhea782027-02
DESPRIN
NCT07835074
P3Not yet recruitingPersistent Allergic Rhinitis3162028-12
TRÍADE-HA
NCT07030101
P3Not yet recruitingHypertension4002029-05 (+3 mo)